Sahin Ugur
USPTO Trademark & Patent Filings
Trademark applications and grants for Sahin Ugur. Sahin Ugur has 5 trademark applications. The latest application filed is for "RESANO"
- Company Aliases
- Sahin, Ugur
- Ugur Sahin
- ugur sahin
- SAHIN; Ugur - Mainz DE
- Sahin; Ugur - Mainz DE
Trademarks Patents
| Patent Application | Date |
|---|---|
| CLAUDIN-6-SPECIFIC IMMUNORECEPTORS AND T CELL EPITOPES 20220306711 - 17/712562 SAHIN; Ugur ; et al. | 2022-09-29 |
| Therapeutic RNA and Anti-PD1 Antibodies for Advanced Stage Solid Tumor Cancers 20220288199 - 17/380251 MASCIARI; Serena ; et al. | 2022-09-15 |
| ANTIGEN-SPECIFIC T CELL RECEPTORS AND T CELL EPITOPES 20220288180 - 17/680021 Sahin; Ugur ; et al. | 2022-09-15 |
| INDIVIDUALIZED VACCINES FOR CANCER 20220282322 - 17/576170 Sahin; Ugur ; et al. | 2022-09-08 |
| RNA CONSTRUCTS AND USES THEREOF 20220273820 - 17/565921 Sahin; Ugur ; et al. | 2022-09-01 |
| Multispecific antibodies against CD40 and CD137 11,440,966 - 17/345,628 Altintas , et al. September 13, 2 | 2022-09-13 |
| Therapy involving antibodies against Claudin 18.2 for treatment of cancer 11,395,852 - 16/158,187 Sahin , et al. July 26, 2 | 2022-07-26 |
| Claudin-6-specific immunoreceptors and t cell epitopes 11,345,731 - 16/444,510 Sahin , et al. May 31, 2 | 2022-05-31 |
| Lipid particle formulations for delivery of RNA and water-soluble therapeutically effective compounds to a target cell 11,337,922 - 17/330,342 Hefesha , et al. May 24, 2 | 2022-05-24 |
| Formulation for administration of RNA 11,318,195 - 16/314,719 Sahin , et al. May 3, 2 | 2022-05-03 |
Mark Image Registration | Serial | Trademark Application Date |
|---|---|
"RESANO" 5946751 79248902 |
RESANO 2018-11-07 |
"MEDINE" 5399662 87314856 |
MEDINE 2017-01-26 |
"IMMUNOPOLIS" 5399663 87314872 |
IMMUNOPOLIS 2017-01-26 |
"MEDINE" 4008342 85057225 |
MEDINE 2010-06-08 |
"IMMUNOPOLIS" 3960587 77967071 |
IMMUNOPOLIS 2010-03-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 